SpaceX is working on a program to use its mammoth Starship rocket to develop commercial products in space, potentially ...

Electra also has preclinical research with an immuno-oncology drug candidate addressing an undisclosed target. Electra has since gone on to raise an $84 million Series B round of financing .

Pharmaceuticals giant Novartis is pinning its hopes on a 43-year-old Harvard cancer research star to help fill gaps in its immuno-oncology arsenal after "missing the boat" on some promising therapies.